ロード中...
Is human hepatocellular carcinoma a hormone-responsive tumor?
Before the positive results recently obtained with multitarget tyrosine kinase inhibitor sorafenib, there was no standard systemic treatment for patients with advanced hepatocellular carcinoma (HCC). Sex hormones receptors are expressed in a significant proportion of HCC samples. Following preclinic...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The WJG Press and Baishideng
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2695908/ https://ncbi.nlm.nih.gov/pubmed/18350599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.1682 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|